1.Clinical Status of Antidepressant Treatment
Chinese Journal of Prevention and Control of Chronic Diseases 2006;0(02):-
Treatment of depression is divided into drug treatment and non-drug treatment. Drug therapy including tricyclic、 tetracyclic antidepressant category、Serotonin reuptake inhibitors (SSRI)、Serotonin receptor antagonist and re-absorption inhibitors (SARI)、norepinephrine and dopamine reuptake inhibitors (NDRI)、 serotonin and norepinephrine reuptake inhibitors (SNRI)、 norepinephrine and specific serotonergic antidepressants (NaSSA) and synergist to support treatment; Non-drugs treatments include psychotherapy, electric shock therapy、transcranial magnetic stimulation (TMS) and deep brain stimulation (DBS)treatment.In clinical practice for a number of studies provide hope that patients with depression.
2.Security issues and corresponding measures in using Clinic Electronic Llinac
Chinese Medical Equipment Journal 2003;0(11):-
This paper briefly introduces some security issues in using Clinic Electronic Llinac and provides corresponding measures and suggestions,which give a reference for persons of the same occupation in security management and operation of Clinic Electronic Llinac.
3.Factors Related with Final Test for Continued Learning of Rehabilitation
Chinese Journal of Rehabilitation Theory and Practice 2013;19(9):899-900
Objective To investigate the factors related with final test for continued learning of rehabilitation. Methods The records of 511 continued learning students for physical therapy were analysed with linear regression, with the results of theoretical and operating test as independent variable, while sex, age, titles, profession, education, works, levels of hospital and evaluations as independent variable. Results The results of both theoretical and operating test related with profession, education, works levels and evaluation. Conclusion The models estimate the results of continued learning for rehabilitation has been established.
5.Intravascular malignant lymphomatosis and Asian variant
Journal of Medical Postgraduates 2004;0(01):-
Because absence of lymphoadenopathy, and often associated with haemophagocytic syndrome, the intravascular malignant lymphoma(IVL) is easy mistaken as malignant histiocytosis or connective tissue disease or vasculitis, the diagnosis was difficult while patients were alive. The clinical course of this disorder (IVL)was aggressive and carried a poor prognosis. The cases of this disorder are not too rare to be seen in our country. To enhance one′s ability to differentiate disorder in unknown fever diseases are extremely necessary.
6.Clinical significance of ADAMTS13 activity in thrombotic thrombocytopenic purpura patients
Journal of Medical Postgraduates 2003;0(03):-
A deficient of plasma VW factor-cleaving protease (ADAMTS13) and appearance of unusually large multimers induced platelets aggregation in capillaries and arterioles. It was critical pathogenesis of thrombotic thrombocytopenia purpura (TTP). ADAMTS13 activity has been measured over 1000patients of TTP and hemolysis uremia syndrome (HUS) since 1997. Diagnostic sensitivity and specificity,as well as clinical significance of ADAMTS13 deficiency for TTP patients were evaluated,and synthetical diagnosis basis of TTP were raised.
7.Monoclonal antibodies in the treatment of malignant lymphoma
Journal of International Oncology 2009;36(5):384-387
In recent years, monoclonal antibody comes to be a new and promising kind of treatment mode for malignant lymphoma, because of its advantages, such as target property, minimal residual of tumor cell in vivo and little side effect. The main methods include single agent therapy, combination with chemothera-py, combination with immunotoxin, radioimmunotherapy and etc.
8.Application of medical polymer carrier materials to anticancer drugs
Chinese Journal of Tissue Engineering Research 2010;14(8):1455-1458
OBJECTIVE: To introduce the type and biological properties of medical polymer vehicle materials, and to evaluate its application in anticancer drugs. METHODS: A computer-based on-line research was performed in China Journal Full-text Database and Pubmed database published from 1990 to 2009. The key words were "polymer, anticancer drug, carrier". Articles concerning biological properties of medical polymer vehicle materials and its application in anticancer drugs were included. Meta analysis and repetitive studies were excluded. RESULTS: Quality of articles was assessed, and a total of 24 articles were included. Biological properties of medical polymer vehicle materials and its application in anticancer drugs were summarized. Medical polymer vehicle materials are novel technique with the development of pharmacological study, biomaterial study and clinical medicine. Good biocompatibility, biodegradability, regulation of degradation rate and good workability of polymer materials provided convenience and possibility for innovation of pharmaceutical preparation. Structure of drug carrier material, elevation of drug-loading efficiency, in vivo distribution, biodegradation function and effects of degradation product on bodies deserved further investigations. The study focus of anticancer drug high polymer carrier lies in the search of carrier materials with strong choice and good outcomes. CONCLUSION: Medical polymer carrier materials can control drug release speed by dosage form changes, which induced a stable drug concentration in vivo. The medical polymer carrier materials also can send drugs to a certain part of the body by release system, which cannot affect other regions in the body.
9.Minimally invasive treatment in early rectal carcinoma
Journal of International Oncology 2013;(5):370-372
Radiotherapy alone and local excision combined with radiotherapy have been alternative treatments of early rectal carcinoma resection.Compared with radical surgery,both radiotherapy alone and local excision combined with radiotherapy can get satisfactory effect,and prevent the high rate of complications and adverse reactions,which will improve the quality of life for patients with rectal carcinoma and should be recommended.
10.Thoughts on building the early-warning system for hospital talents drainage
Chinese Journal of Hospital Administration 2009;25(5):342-343
In line with the hospital development practice in recent years,this paper discussed the early-warning system for hospital talents drainage.First of all,it points out that early-warning indicators,early-warning analysis and early-control measures are key elements of such a system.On this basis,it pinpoints key points in building this system,including organizational assurance,by-level management,dynamic tracking,fairness,bettering of HR mechanism,and reservation of potential HR resources.Therefore,this will be highly useful and practical for studying how to minimize talents drainage and maintain competitive advantages of hospitals.